tropic (infecting only nonmurine cells), and dual-tropic (infecting murine and mink cells). Using human cells, for example, we allocated 2.5 retrovirus strains to eight distinct receptor groups through receptor cross-interference studies. Figure 1 depicts the six membrane proteins currently known to act as receptors for retroviruses. Mechanisms of Retrovirus Entry The binding of virions to cell surface receptors is but the first step in virus entry. The events that lead to fusion of the retrovirus envelope with cellular membranes are not yet clear. Most retroviruses studied can fuse with cell membranes at neutral pH, so the mode of entry does not depend on receptor-mediated endocytosis via acidic endosomes (Weiss, 1993) . Ecotropic murine leukemia virus (MLV-E), however, is pH-dependent in some cell types, possibly relying on cleavage of gp70 by pH-dependent cathepsins.
Each molecule shown in Figure 1 serves as the primary binding receptor for its virus, with the sites that affect binding and infection (where known) shown by arrows. Although the receptors represent quite distinct families of membrane proteins, the binding sites for several retroviruses (HIV, MLV-E, and ALV-A) have a common triplet motif requiring an acidic or noncharged amino acid and an aromatic one (Zingler et al., 1995) . Subsequent to virus binding, conformational changes of the receptor, as well as of the viral envelope antigens, may occur, as analyzed in most detail for CD4 (see Littman, 1995; Weiss, 1993; Wimmer, 1994) . The envelope glycoproteins of retroviruses consist of oligomers of the transmembrane (TM) protein each bearing surface (SU) glycoproteins. The SU protein mediates binding to specific cellular receptors, whereas fusion is dependent on both SU and TM. The epitopes for CD4 binding on the HIV SU protein gp120 are discontinuous (Weiss, 1993) , as are those of the MLV SU protein gp70 (Battini et al., 1995) .
For HIV, binding to CD4 is not sufficient for entry. Sec- References: CD4, CAT, Ram-l, and GLVRl (reviewed by Wimmer, 1994) ; CAT (Albritton et al., 1993) ; Ram-l van Zeijl et al., 1994) ; GLVRl Tailor et al., 1993) ; bovine leukemiavirus (BLV) (Ban et al., 1993) ; ALV-A (Bates et al., 1993) . Amino acid sequence of region A (residues 550-558) of GLVRI from different species Tailor et al., 1993; Wilson et al., 1994b) . The amino acid numbering of human GLVRl is adopted for each receptor protein, Identical amino acids to human GLVRI are indicated by elipses. nt, not tested.
ondary receptors are required to trigger fusion (Weiss, 1993) . The variable loops on gp120, VlN2, and V3 determine the secondary tropisms of HIV-1 for CDCpositive T helper lymphocytes and macrophages. These epitopes, which are also the principle neutralizing antigens, interact with secondary glycolipids, which may be receptors (Dragic et al., 1995) . One glycolipid that can act as a primary binding receptor for HIV-1 is galactosyl ceramide, although it is not an efficient receptor for HIV entry. Gp120 interaction with receptors other than CD4 may play a role in brain pathogenesis, as gpl20 expression in the brains of transgenic mice induces degenerative changes similar to those seen in AIDS dementia (Toggas et al., 1994) . HIV-2 recognizes different secondary receptors from HIV-1 and can fuse and enter a wider variety of CD4-positive cells (McKnight et al., 1994) . HIV-2 also infects some CD4-negative cells for which soluble CD4 enhances rather than inhibits infection (Weiss, 1993; Talbot et al., 1995) . Transporter
Receptors: Specificity and Function The receptors with multiple membrane-spanning domains shown in Figure 1 function as transporter molecule8 (see Wimmer, 1994) . The MLV-E receptor is a cationic amino acid transporter (CAT) for arginine, lysine, and ornithine (Kim et al., 1991; Wang et al., 1991) . GLVRl, the receptor for gibbon ape leukemia virus (GALV) and feline leukemia virus B (FeLV-B), and Ram-l, the receptor for MLV-A, are both Pi (inorganic phosphate) transporters. Whereas CAT functions independently of Na', GLVRl and Ram-l are dependent on Na+ and transport is inhibited if the Na+ is replaced by K+ or Lif (Kavanaugh et al., 1994; Clah et al., 1994) .
The amino acid sequences of these transporter molecules are highly conserved among eukaryotes, reflecting the unchanging nature of their crucial housekeeping functions in cell membranes.
However, the epitopes that are critical for virus binding and infection vary greatly among mammalian species without affecting transport function. One or few amino acids determine permissivity for infection. The inability of human CAT to function as a receptor for MLV-E is attributable to variation of two amino acids of the third extracellular loop PGV (242) (243) (244) as opposed to in murine CAT (Albritton et al., 1993) . Similarly, sequence variation in the fourth extracellular loop (region A; residues 550-558) of GLVRl accounts for the differential in permissivity of human, rat, and murine GLVRl to GALVand FeLV-B (Figure2) (Tailoret al., 1993) . Variation within this region may also account for the inability of Ram-l to function for GALV. The Ram-l homolog in hamster E36 cells (EAR) can function as a receptor for GALV as well as for MLV-A (Wilson et al., 1994a) .
The 10Al strain of MLV utilizes both GLVRl and Ram-l (Wilson et al., 1994a) , showing that related type C mammalian viruses can utilize closely related molecules as receptors. The receptors for xenotropic and dualtropic MLV have yet to be, identified, but the high homology of their envelopes with MLV-A and FeLV-B envelopes suggests that these viruses may utilize related transporter molecules as receptors.
We may speculate that the variability of the virus-binding epitopes on receptors from different host species results in part from natural selection for virus resistance. For instance, the amino acid sequence of the GLVRl virusbinding epitope is shown in Figure 2 . The sequence in humans and carnivores is identical, yet there is extraordinary variation among rodent species, even within the genus Mus. GALV is an exogenous, horizontally transmitted leukemogenic virus of gibbon apes in South East Asia. However, GALV may represent a recent zoonotic infection of gibbons from an endogenous retroviral genome of mice (M. caroli) that are also indigenous in Southeast Asia (Lieber et al., 1975) . Indeed, there is no evidence that wild arboreal gibbons are naturally infected with GALV, though the virus spread in captive colonies. The GLVRl receptor sequences of most murine species are not permissive for GALV infection. It is possible that they mutated to evolve resistance to prevent viremia from activated endogenous virus. In other words, receptor mutation subsequent to the acquisition and transgenesis of an endogenous virus may render it xenotropic or at least nonecotropic. Does Virus Infection Affect Normal Receptor Function? Many retroviruses are able to establish persistent infections without obvious cytopathic effects. Yet sufficient envelope glycoproteins are synthesized in persistent, productive infection to cause resistance (interference) to superinfection through blocking or down-modulation of receptors. It follows that receptor interference is not always lethal to cellular functions. The binding of excess gp120 to CD4 can inhibit CD4-MHC class II interactions, and down-modulation of CD4 by HIV gpl20, Nef, and Vpu presumably renders a T helper lymphocyte anergic. The possible effect of gp120 binding to Gal-Cer glycolipid in the brain has already been mentioned.
The binding of type C viral gp70 to receptors does not entirely inhibit their natural permease functions. Amino acid transport through the CAT receptor is diminished by MLV-E (Wang et al., 1992) , and Pi transport via GLVRI and Ram-l is inhibited by GALV and MLV-A, respectively (Kavanaugh et al., 1994; Olah et al., 1994) . It remains to be determined whether cell survival following productive retrovirus infection is possible because gp70 incompletely blocks physiological transport or because there is redundancy among transporter systems. As Pi starvation upregulates GLVRl and Ram-l (Kavanaugh et al., 1994) , any inhibition of Pi transport in cells productively infected with either GALV or MLV-A might be compensated for by the up-regulation of the "free" transporter. While the double infection by GALV and MLV-A of dually permissive cells might block Pi transport sufficiently to cause a deleterious effect, it is also feasible that other Pi transporters, which do not function as receptors for either GALV or MLV-A, may exist to compensate for the inhibition of Pi transport by GLVRl and Ram-i.
It should be borne in mind that viral interference has been studied in vitro, and the levels of virus glycoprotein production in vivo may be insufficient to block the normal functions of retroviral receptors. However, endogenous viral glycoprotein expression can saturate receptors sufficiently to block infection in vivo, as exemplified by the Mendelian dominant resistance of chickens expressing endogenous envelope to ALV-E infection and an analog in mice, the Fv-4 locus (reviewed by Weiss, 1993) .
The interaction of retroviral glycoproteins with cell surface receptors can also result in receptor activation. This is exemplified by the association of Friend erythroleukemia virus gp55 with the erythroprotein receptor (EpoR). Gp55 is an aberrant, recombinant envelope glycoprotein encoded by the replication-defective, spleen focus-forming component of Friend virus, and it does not mediate virion entry. But it activates signal transduction by EpoR in the absence of Epo, thus promoting erythroid proliferation (Li et al., 1995) .
Targeting Novel Receptors with Retroviral Vectors
The Ram-l and GLVRl receptors are broadly expressed in human tissues , as are receptors for the RD114 feline envelope that resists inactivation by human complement (Takeuchi et al., 1994) . There is growing interest, however, in modifying retroviral envelopes to target cell types more specifically. Kasahara et al. (1994) reported targeting of retroviral vectors to EpoR through the incorporation of Epo into gp70. Somia et al. (1995) have produced an efficient vector targeted to the low density lipoprotein receptor by insertion into ecotropic env of a single-chain immunoglobulin fragment specific to low density lipoprotein receptor. Oligomeric envelope spikes containing wild-type gp70 and modified gp70 may increase efficiency of infection (Chu and Dornburg, 1995) . However, while insertion of an epidermal growth factor motif specifically targeted retroviral particles to cells expressing epidemal growth factor receptors, infection was inefficient (Cosset et al., 1995) . These results indicate that modified gp70-containing ligands for nonviral receptors can, but do not always, serve as functional viral glycoprois likely to provide improved specificity of vectors for gene therapy.
